Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/1999
08/26/1999WO1999042453A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
08/26/1999WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments
08/26/1999WO1999042124A1 Liquid crystal forms of cyclosporin
08/26/1999WO1999042105A1 Epimorphian compound and its use
08/26/1999WO1999042102A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
08/26/1999WO1999042101A1 Dietary control of arachidonic acid metabolism
08/26/1999WO1999033989A3 Rantes mutants and therapeutic applications thereof
08/26/1999WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/26/1999WO1999028342A3 Low-voltage activated calcium channel compositions and methods
08/26/1999WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
08/26/1999WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
08/26/1999DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction
08/26/1999CA2321182A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
08/26/1999CA2318959A1 Epimorphian compound and its use
08/25/1999EP0937777A2 GABA receptors and their uses
08/25/1999EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors
08/25/1999EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
08/25/1999EP0937102A1 Human monocyte chemotactic proprotein
08/25/1999EP0937100A1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof
08/25/1999EP0937099A1 Oligomers which inhibit the expression of interleukin genes
08/25/1999EP0937076A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
08/25/1999EP0937075A1 New imidazopyridines and oxazolopyridines
08/25/1999EP0937069A1 Piperazino derivatives as neurokinin antagonists
08/25/1999EP0937065A1 Constrained somatostatin agonists and antagonists
08/25/1999EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists
08/25/1999EP0937041A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
08/25/1999EP0937035A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
08/25/1999EP0936905A1 Immediate wettability water soluble film or water soluble layer for oral application
08/25/1999EP0667858B1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
08/25/1999EP0612321B1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity
08/25/1999CN1226892A Compounds and compositions for treating diseases associated with tryptase activity
08/25/1999CN1226436A Chinese medicine composition for rhinitis and preparing method thereof
08/25/1999CN1226422A Percutaneous absorption type preparation
08/24/1999US5942622 Novel compounds for treating illness resulting from abnormal stimulation of endothelial receptors; for example: 4-((6-chloro-1,3-benzodioxol-5-yl)methyl)-1-(cyclohexylmethyl) -3-(2-pyridinyl)-1h-pyrazole-5-carboxylate
08/24/1999US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof
08/24/1999US5942523 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
08/24/1999US5942521 Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient
08/24/1999US5942515 Pyrrolopyrazolopyrimidine compound and medicine comprising the same as active ingredient
08/24/1999US5942497 Purine compound and catecholamine compound containing compositions and methods for administration
08/24/1999US5942419 RsbW-1 encoding nucleic acids
08/24/1999CA2193348C Substituted alkyldiamine derivatives and their use as tachykinin antagonists
08/24/1999CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/24/1999CA2147126C Piperidine derivatives and process for their production
08/20/1999CA2249653A1 Novel compounds
08/19/1999WO1999041402A2 Targeting of genetic vaccine vectors
08/19/1999WO1999041369A2 Genetic vaccine vector engineering
08/19/1999WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999WO1999040939A1 Method for the prevention and treatment of a type i hypersensitivity disorder
08/19/1999WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999WO1999040910A1 Anti-inflammatory agents
08/19/1999WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
08/19/1999WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/19/1999WO1999016419A9 Perforated microparticles and methods of use
08/19/1999DE19806438A1 New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer
08/19/1999CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999CA2320626A1 Genetic vaccine vector engineering
08/19/1999CA2320515A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999CA2320285A1 Anti-inflammatory agents
08/19/1999CA2320104A1 Method for the prevention and treatment of a type i hypersensitivity disorder
08/19/1999CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/18/1999EP0936216A1 Novel acetamide derivatives and protease inhibitors
08/18/1999EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
08/18/1999EP0935470A1 Method for treating allergic lung disease
08/18/1999EP0935465A1 Novel substituted imidazole compounds
08/18/1999EP0935415A1 Methods for delivering compounds into a cell
08/18/1999EP0896537B1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
08/18/1999EP0682662B1 Bicyclic carboxylic acid leukotriene b4 antagonists
08/18/1999CN1226171A Type-2 chemokine binding proteins and methods of use thereof
08/18/1999CN1226169A Use of uridine triphosphates and related compounds for prevention and treatment of pneumonia in immobilized patients
08/17/1999US5939525 Methods of treating inflammation and compositions therefor
08/17/1999US5939462 NPY5 receptor antagonists and methods for using same
08/17/1999US5939452 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists
08/17/1999US5939447 Substituted benzopyrans
08/17/1999US5939433 Quinuclidine derivatives
08/17/1999US5939422 An enzyme inhibitor as bronchodilator, relaxants, antiinflammatory agent for treating asthma, allergies, inflammation, depression, dementia, diseases associated with abnormal high level of cytokine
08/17/1999US5939415 A!-annellated pyrrole derivatives and their use in pharmacology
08/17/1999US5939413 Tachykinin mediated diseases in humans for respiratory system disorders like asthma, bronchitis, rhinitis or eye diseases or skin disorders
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939405 Potassium channel modulators
08/17/1999US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents
08/17/1999CA2179008C 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
08/12/1999WO1999040111A1 The aiolos gene
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999WO1999040083A2 Bifunctional tryptase inhibitors
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040073A2 Tryptase inhibitors
08/12/1999WO1999039729A2 Use of heregulin as an epithelial cell growth factor
08/12/1999WO1999029339A3 Prevention and/or treatment of allergic conditions
08/12/1999WO1999028304A3 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 878